PACS Group Q4 EPS Misses by 9.5%, Revenue Up 12% to $1.36B
PACS Group delivered fourth-quarter EPS of $0.43 per share, missing the $0.48 consensus by 9.5% while revenue rose 12.4% year-over-year to $1.36 billion and beat the $1.30 billion estimate by 4.8%. This marks the fourth consecutive quarter the company has failed to top EPS forecasts.
1. Fourth-Quarter Financial Results
PACS Group reported adjusted EPS of $0.43 in the December quarter, falling 9.5% short of the $0.48 consensus and up from $0.25 a year earlier. Revenue climbed 12.4% to $1.36 billion, surpassing estimates by 4.8%.
2. Recent Earnings Trend
This marks the fourth straight quarter PACS Group has missed EPS consensus estimates, following surprises of -30.4% in the prior quarter and similar shortfalls earlier in the year. The pattern raises concerns over the company’s ability to sustain profitability above analyst forecasts.
3. Outlook and Analyst Estimates
Analysts currently project $0.43 EPS and $1.36 billion in revenue for the upcoming quarter and full-year estimates of $2.00 EPS on $5.36 billion in revenue. Mixed estimate revisions reflect uncertainty in the medical services industry, which ranks in the bottom 39% of its peer group.